PT-141 Nasal
For Research Use Only
Nasal
A cyclic melanocortin-receptor agonist peptide studied in central nervous system signaling research. Work examines melanocortin pathway activation distinct from peripheral vasodilatory mechanisms in receptor assays. Laboratory research areas include: melanocortin receptor pharmacology, central signaling assays, and peptide agonist research.
Size: 10mg
$275.00
Out of stockThis size is out of stock. Choose another size, or request it below.
Checkout opens once payment is connected.
Certificates of analysis
No certificate has been published for this product yet.
Research guides
- PT-141 (Bremelanotide) and Melanocortin Receptor Signalling: A Research OverviewA citation-indexed survey of the published literature on PT-141 (bremelanotide), a synthetic alpha-MSH analogue characterised as an agonist at melanocortin receptors MC3R and MC4R, covering receptor pharmacology, preclinical models, and the human trial record.
- PT-141 (Bremelanotide): What the Published Research ReportsA citation-indexed overview of the published literature on PT-141 (bremelanotide), a cyclic melanocortin receptor agonist peptide, covering receptor structural work in vitro, rodent and hamster mechanistic models, randomized human trials in sexual dysfunction populations, reported adverse-event profiles, and analytical and delivery studies.
This product is not for human or animal consumption. Misuse of this product is illegal.